The current prices are delayed, login to your account for live prices
Login
Logo

TRANSGENE BIOTEK LTD. Share Price

526139
₹ 2.94
-₹0.03 (-1.01%)
1D
Last updated 12 Jun, 2026, 15:29 IST
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
₹2.90
1.01% down today
₹3.08
1D LOW
1D HIGH
Open
₹2.97
High
₹3.08
Low
₹2.90
Prev. close
₹2.97
Circuit
L
H
₹2.36
₹3.52
52-week
L
H
₹1.83
₹5.26

TRANSGENE BIOTEK LTD. Shareholder Returns

TRANSGENE BIOTEK LTD. Share Price History

Mkt Cap Cr
22.28
P/E
-13.36
P/B
2.66
ROE
-19.73%
D/E
-1.86
ROCE
-2.32%
Div. Yield
—
EPS(TTM)
-0.22
Turnover
—
EV/EBITDA
-100.91
Net Margin
0.00%
Op. Margin
0.00%
ROA
-1.15%
Quick Ratio
0.00
Curr. Ratio
0.36
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Transgene Biotek has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Transgene Biotek appears overvalued compared to its peers
Step 2 of 5
Earnings
Poor
Transgene Biotek earnings have been degrowing

TRANSGENE BIOTEK LTD. Financials

Full statement
Consolidated - Yearly
All values are in INR Crore
Consolidated
Annually
* All values are in INR Crore
Qty
Bid
4627
2.94
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 4627
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
4
Bullish
3
Slightly Bullish
Indicator
Value
Verdict
RSI (14)
45.32
Neutral
ATR (14)
0.22
Neutral
STOCH(9,6)
22.5
Neutral
STOCH RSI (14)
12.9
Bullish
ADX(9)
17.08
Bullish
UO(9)
40.85
Neutral
ROC(12)
-6.07
Bearish
WillR(14)
-82
Bullish
Period
Simple value
Exponential vaue
5D
2.98
2.98
10D
3.04
3.02
20D
3.1
3.05
50D
2.91
2.95
100D
2.68
2.92
About TRANSGENE BIOTEK LTD.
TRANSGENE BIOTEK LTD. logo
NSE Symbol
-
BSE Symbol
BSE: 526139
ISIN
INE773D01018
Sector Market Cap
₹ 22.28 Cr

Transgene Biotek Limited is an India-based biotechnology company. It is engaged in the research and development of vaccines, oncology, and new drug delivery technologies. Its portfolio of products includes oncology, autoimmunity, drug delivery and biogenetics. The Company offers TrabiAAV, which is a platform for the delivery of micro-ribonucleic acids (miRNAs), short hairpin RNA (ShRNAs), immunogens developing clinical significance in gene therapy and CRISPR/cas 9 technologies. Its monoclonal antibody therapy is the use of monoclonal antibodies to specifically bind to target cells. Its TrabiORAL drug is focused on delivering proteins and peptides orally for a variety of human diseases. Its TBL-1203 drug is used to strengthen cell-mediated immunity and complete the elimination of the human immunodeficiency virus (HIV), without any need for retroviral drug therapy. Its Tacrolimus drug suppresses the immune system and is mainly used to prevent rejection of transplanted organs.As of 14 Jun 2026, TRANSGENE BIOTEK LTD. share price is ₹2.94. The stock opened at ₹2.97, compared to its previous close of ₹2.97. During today's trading session, TRANSGENE BIOTEK LTD. share price moved in the range of ₹2.90 to ₹3.08, with an average price of ₹2.99 for the day. Looking at its last 52-week, the stock has touched a low of ₹2.90 and a high of ₹3.08.

The market capitalization of TRANSGENE BIOTEK LTD. is ₹22 Crs, with a P/E ratio of -13.4 and a dividend yield of 0.00%.

FAQs on TRANSGENE BIOTEK LTD.